Literature DB >> 16905792

Preexposure prophylaxis for HIV: unproven promise and potential pitfalls.

Albert Y Liu1, Robert M Grant, Susan P Buchbinder.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16905792     DOI： 10.1001/jama.296.7.863

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  38 in total

Review 1.  Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Trends Microbiol       Date:  2012-04-12       Impact factor: 17.079

2.  Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.

Authors:  Jaclyn M White; Matthew J Mimiaga; Douglas S Krakower; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2012-06-13       Impact factor: 5.078

3.  Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes.

Authors:  J Carlo Hojilla; Kimberly A Koester; Stephanie E Cohen; Susan Buchbinder; Deawodi Ladzekpo; Tim Matheson; Albert Y Liu
Journal:  AIDS Behav       Date:  2016-07

4.  A US policy perspective on oral preexposure prophylaxis for HIV.

Authors:  Arleen A Leibowitz; Karen Byrnes Parker; Mary Jane Rotheram-Borus
Journal:  Am J Public Health       Date:  2011-04-14       Impact factor: 9.308

5.  Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.

Authors:  S Wade Taylor; Kenneth H Mayer; Steven M Elsesser; Matthew J Mimiaga; Conall O'Cleirigh; Steven A Safren
Journal:  AIDS Behav       Date:  2014-05

Review 6.  Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies.

Authors:  Lisa A Eaton; Seth Kalichman
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

7.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

8.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

9.  Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors:  Kristen Underhill
Journal:  Am J Law Med       Date:  2012

10.  Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.

Authors:  Paul W Denton; John F Krisko; Daniel A Powell; Melissa Mathias; Youn Tae Kwak; Francisco Martinez-Torres; Wei Zou; Deborah A Payne; Jacob D Estes; J Victor Garcia
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.